259 related articles for article (PubMed ID: 14500363)
1. Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene.
Ma W; Tessarollo L; Hong SB; Baba M; Southon E; Back TC; Spence S; Lobe CG; Sharma N; Maher GW; Pack S; Vortmeyer AO; Guo C; Zbar B; Schmidt LS
Cancer Res; 2003 Sep; 63(17):5320-8. PubMed ID: 14500363
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility to vascular neoplasms but no increased susceptibility to renal carcinogenesis in Vhl knockout mice.
Kleymenova E; Everitt JI; Pluta L; Portis M; Gnarra JR; Walker CL
Carcinogenesis; 2004 Mar; 25(3):309-15. PubMed ID: 14604887
[TBL] [Abstract][Full Text] [Related]
3. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor.
Rankin EB; Tomaszewski JE; Haase VH
Cancer Res; 2006 Mar; 66(5):2576-83. PubMed ID: 16510575
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the tumor suppressor gene von Hippel-Lindau (VHL) in granulocytes contributes to development of liver hemangiomas in a mouse model.
Bader HL; Hsu T
BMC Cancer; 2016 Oct; 16(1):797. PubMed ID: 27733136
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the arylhydrocarbon receptor nuclear translocator (Arnt) suppresses von Hippel-Lindau disease-associated vascular tumors in mice.
Rankin EB; Higgins DF; Walisser JA; Johnson RS; Bradfield CA; Haase VH
Mol Cell Biol; 2005 Apr; 25(8):3163-72. PubMed ID: 15798202
[TBL] [Abstract][Full Text] [Related]
6. Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.
Haase VH; Glickman JN; Socolovsky M; Jaenisch R
Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1583-8. PubMed ID: 11171994
[TBL] [Abstract][Full Text] [Related]
7. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene.
Kuzmin I; Duh FM; Latif F; Geil L; Zbar B; Lerman MI
Oncogene; 1995 Jun; 10(11):2185-94. PubMed ID: 7784063
[TBL] [Abstract][Full Text] [Related]
8. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
[TBL] [Abstract][Full Text] [Related]
9. Multifocal bilateral renal cell carcinoma and retinal angiomas in a patient with de novo von Hippel-Lindau disease: identification of a new germline mutation.
Sessa A; Battini G; Meroni M; Pitingolo F; Righetti M; Ciotti P; Di Maria E; Bellone E; Ajmar F; Mandich P
J Nephrol; 2005; 18(2):209-12. PubMed ID: 15931650
[TBL] [Abstract][Full Text] [Related]
10. Toxicity of ligand-dependent Cre recombinases and generation of a conditional Cre deleter mouse allowing mosaic recombination in peripheral tissues.
Hameyer D; Loonstra A; Eshkind L; Schmitt S; Antunes C; Groen A; Bindels E; Jonkers J; Krimpenfort P; Meuwissen R; Rijswijk L; Bex A; Berns A; Bockamp E
Physiol Genomics; 2007 Sep; 31(1):32-41. PubMed ID: 17456738
[TBL] [Abstract][Full Text] [Related]
11. EAF2 loss enhances angiogenic effects of Von Hippel-Lindau heterozygosity on the murine liver and prostate.
Pascal LE; Ai J; Rigatti LH; Lipton AK; Xiao W; Gnarra JR; Wang Z
Angiogenesis; 2011 Sep; 14(3):331-43. PubMed ID: 21638067
[TBL] [Abstract][Full Text] [Related]
12. Inducible gene inactivation in neurons of the adult mouse forebrain.
Erdmann G; Schütz G; Berger S
BMC Neurosci; 2007 Aug; 8():63. PubMed ID: 17683525
[TBL] [Abstract][Full Text] [Related]
13. von Hippel-Lindau disease: recent advances and therapeutic perspectives.
Richard S;
Expert Rev Anticancer Ther; 2003 Apr; 3(2):215-33. PubMed ID: 12722881
[TBL] [Abstract][Full Text] [Related]
14. VHL and PTEN loss coordinate to promote mouse liver vascular lesions.
Chen S; Sanford CA; Sun J; Choi V; Van Dyke T; Samulski RJ; Rathmell WK
Angiogenesis; 2010 Mar; 13(1):59-69. PubMed ID: 20221685
[TBL] [Abstract][Full Text] [Related]
15. Cre-mediated recombination in the skin melanocyte lineage.
Delmas V; Martinozzi S; Bourgeois Y; Holzenberger M; Larue L
Genesis; 2003 Jun; 36(2):73-80. PubMed ID: 12820167
[TBL] [Abstract][Full Text] [Related]
16. Targeted disruption of the heat shock transcription factor (hsf)-2 gene results in increased embryonic lethality, neuronal defects, and reduced spermatogenesis.
Wang G; Zhang J; Moskophidis D; Mivechi NF
Genesis; 2003 May; 36(1):48-61. PubMed ID: 12748967
[TBL] [Abstract][Full Text] [Related]
17. Conditional knockout of the mouse NADPH-cytochrome p450 reductase gene.
Wu L; Gu J; Weng Y; Kluetzman K; Swiatek P; Behr M; Zhang QY; Zhuo X; Xie Q; Ding X
Genesis; 2003 Aug; 36(4):177-81. PubMed ID: 12929087
[TBL] [Abstract][Full Text] [Related]
18. HST-1/FGF-4 gene activation induces spermatogenesis and prevents adriamycin-induced testicular toxicity.
Yamamoto H; Ochiya T; Tamamushi S; Toriyama-Baba H; Takahama Y; Hirai K; Sasaki H; Sakamoto H; Saito I; Iwamoto T; Kakizoe T; Terada M
Oncogene; 2002 Jan; 21(6):899-908. PubMed ID: 11840335
[TBL] [Abstract][Full Text] [Related]
19. Deciphering von Hippel-Lindau (VHL/Vhl)-associated pancreatic manifestations by inactivating Vhl in specific pancreatic cell populations.
Shen HC; Adem A; Ylaya K; Wilson A; He M; Lorang D; Hewitt SM; Pechhold K; Harlan DM; Lubensky IA; Schmidt LS; Linehan WM; Libutti SK
PLoS One; 2009; 4(4):e4897. PubMed ID: 19340311
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of the murine pyruvate dehydrogenase (Pdha1) gene and its effect on early embryonic development.
Johnson MT; Mahmood S; Hyatt SL; Yang HS; Soloway PD; Hanson RW; Patel MS
Mol Genet Metab; 2001 Nov; 74(3):293-302. PubMed ID: 11708858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
